Tobacco plants used to develop new rabies treatment

02/3/2013 | News-Medical.Net

In an attempt to create a more cost-effective treatment for people in impoverished countries who are infected with the rabies virus, researchers in London developed a monoclonal antibody to rabies using leaves of the tobacco plant. The antibody blocks the virus from adhering to nerve endings at the site of the initial bite. "An untreated rabies infection is nearly 100% fatal and is usually seen as a death sentence. Producing an inexpensive antibody in transgenic plants opens the prospect of adequate rabies prevention for low-income families in developing countries," said researcher Leonard Both.

View Full Article in:

News-Medical.Net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA